Nanoparticles and Direct Immunosuppression

Overview

Journal Exp Biol Med (Maywood)

Specialty Biology

Date 2016 May 28

PMID 27229901

Citations 22

Authors

Terrika A Ngobili

Michael A Daniele

Affiliations

Soon will be listed here.

Abstract

Targeting the immune system with nanomaterials is an intensely active area of research. Specifically, the capability to induce immunosuppression is a promising complement for drug delivery and regenerative medicine therapies. Many novel strategies for immunosuppression rely on nanoparticles as delivery vehicles for small-molecule immunosuppressive compounds. As a consequence, efforts in understanding the mechanisms in which nanoparticles directly interact with the immune system have been overshadowed. The immunological activity of nanoparticles is dependent on the physiochemical properties of the nanoparticles and its subsequent cellular internalization. As the underlying factors for these reactions are elucidated, more nanoparticles may be engineered and evaluated for inducing immunosuppression and complementing immunosuppressive drugs. This review will briefly summarize the state-of-the-art and developments in understanding how nanoparticles induce immunosuppressive responses, compare the inherent properties of nanomaterials which induce these immunological reactions, and comment on the potential for using nanomaterials to modulate and control the immune system.

Citing Articles

Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery.

Lansberry T, Stabler C Adv Drug Deliv Rev. 2024; 206:115179.

PMID: 38286164 PMC: 11140763. DOI: 10.1016/j.addr.2024.115179.

Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy.

Kiaie S, Salehi-Shadkami H, Sanaei M, Azizi M, Shokrollahi Barough M, Nasr M J Nanobiotechnology. 2023; 21(1):339.

PMID: 37735656 PMC: 10512572. DOI: 10.1186/s12951-023-02083-y.

Progress in nanoparticle-based regulation of immune cells.

Fan Y, Zhao G, Zhang Y, Ye Q, Sun Y, Shen S Med Rev (2021). 2023; 3(2):152-179.

PMID: 37724086 PMC: 10471115. DOI: 10.1515/mr-2022-0047.

Challenges and advances for glioma therapy based on inorganic nanoparticles.

Hu D, Xia M, Wu L, Liu H, Chen Z, Xu H Mater Today Bio. 2023; 20:100673.

PMID: 37441136 PMC: 10333687. DOI: 10.1016/j.mtbio.2023.100673.

Recurrent flares of verruca plana arising at the site of embedded metal shrapnel exacerbated by UV exposure.

Russell E, Treichel A, Honda K, Rady P, Tyring S, Cooper K JAAD Case Rep. 2023; 35:25-27.

PMID: 37078014 PMC: 10106338. DOI: 10.1016/j.jdcr.2023.02.023.

References

Chen H, Dorrigan A, Saad S, Hare D, Cortie M, Valenzuela S . In vivo study of spherical gold nanoparticles: inflammatory effects and distribution in mice. PLoS One. 2013; 8(2):e58208. PMC: 3585265. DOI: 10.1371/journal.pone.0058208. View

Rudra J, Tian Y, Jung J, Collier J . A self-assembling peptide acting as an immune adjuvant. Proc Natl Acad Sci U S A. 2010; 107(2):622-7. PMC: 2818904. DOI: 10.1073/pnas.0912124107. View

van Gelder T, van Schaik R, Hesselink D . Pharmacogenetics and immunosuppressive drugs in solid organ transplantation. Nat Rev Nephrol. 2014; 10(12):725-31. DOI: 10.1038/nrneph.2014.172. View

Sumbayev V, Yasinska I, Pascual Garcia C, Gilliland D, Lall G, Gibbs B . Gold nanoparticles downregulate interleukin-1β-induced pro-inflammatory responses. Small. 2012; 9(3):472-7. DOI: 10.1002/smll.201201528. View

Lee S, Song W, Cho M, Puppala H, Nguyen P, Zhu H . Antioxidant properties of cerium oxide nanocrystals as a function of nanocrystal diameter and surface coating. ACS Nano. 2013; 7(11):9693-703. DOI: 10.1021/nn4026806. View

Bregoli L, Chiarini F, Gambarelli A, Sighinolfi G, Gatti A, Santi P . Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. Toxicology. 2009; 262(2):121-9. DOI: 10.1016/j.tox.2009.05.017. View

Black M, Trent A, Kostenko Y, Lee J, Olive C, Tirrell M . Self-assembled peptide amphiphile micelles containing a cytotoxic T-cell epitope promote a protective immune response in vivo. Adv Mater. 2012; 24(28):3845-9. DOI: 10.1002/adma.201200209. View

Hanley C, Thurber A, Hanna C, Punnoose A, Zhang J, Wingett D . The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction. Nanoscale Res Lett. 2010; 4(12):1409-20. PMC: 2894345. DOI: 10.1007/s11671-009-9413-8. View

Nadig S, Dixit S, Levey N, Esckilsen S, Miller K, Dennis W . Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity. RSC Adv. 2015; 5(54):43552-43562. PMC: 4494678. DOI: 10.1039/C5RA04057D. View

10.

Shaunak S, Thomas S, Gianasi E, Godwin A, Jones E, Teo I . Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat Biotechnol. 2004; 22(8):977-84. DOI: 10.1038/nbt995. View

11.

Ilinskaya A, Dobrovolskaia M . Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol. 2014; 171(17):3988-4000. PMC: 4243973. DOI: 10.1111/bph.12722. View

12.

Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R . Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol. 2013; 8(10):772-81. DOI: 10.1038/nnano.2013.181. View

13.

Zakrzewski J, van den Brink M, Hubbell J . Overcoming immunological barriers in regenerative medicine. Nat Biotechnol. 2014; 32(8):786-94. PMC: 4409427. DOI: 10.1038/nbt.2960. View

14.

Metselaar J, Wauben M, Wagenaar-Hilbers J, Boerman O, Storm G . Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum. 2003; 48(7):2059-66. DOI: 10.1002/art.11140. View

15.

Hayder M, Poupot M, Baron M, Nigon D, Turrin C, Caminade A . A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Sci Transl Med. 2011; 3(81):81ra35. DOI: 10.1126/scitranslmed.3002212. View

16.

Shukla N, Salunke D, Balakrishna R, Mutz C, Malladi S, David S . Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer. PLoS One. 2012; 7(8):e43612. PMC: 3429503. DOI: 10.1371/journal.pone.0043612. View

17.

Wu H, Chung M, Wang C, Huang C, Liang H, Jan T . Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells. Part Fibre Toxicol. 2013; 10:46. PMC: 3851143. DOI: 10.1186/1743-8977-10-46. View

18.

Frick S, Bacher N, Baier G, Mailander V, Landfester K, Steinbrink K . Functionalized polystyrene nanoparticles trigger human dendritic cell maturation resulting in enhanced CD4+ T cell activation. Macromol Biosci. 2012; 12(12):1637-47. DOI: 10.1002/mabi.201200223. View

19.

James L, Xu Z, Sluyter R, Hawksworth E, Kelso C, Lai B . An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase. J Inorg Biochem. 2014; 142:28-38. DOI: 10.1016/j.jinorgbio.2014.09.013. View

20.

Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson K . Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A. 2008; 105(38):14265-70. PMC: 2567179. DOI: 10.1073/pnas.0805135105. View